VBI Vaccines announces phase 2a trial of VBI-1901 plus AS01B adjuvant system in recurrent glioblastoma

Image: VBI Vaccines announces phase 2a trial of VBI-1901 cancer vaccine candidate in combination with AS01B adjuvant system in recurrent glioblastoma patients. Photo: courtesy of PublicDomainPictures from Pixabay.